Stainsby D, Jones H, Asher D, et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 2006;20:273–82.10.1016/j.tmrv.2006.05.00217008165Search in Google Scholar
Wendel S, Biagini S, Trigo F, et al. Measures to prevent TRALI. Vox Sang 2007;92:258–77.10.1111/j.1423-0410.2006.00870.x17348877Search in Google Scholar
U.S. Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2009. Rockville, MD: U.S. Department of Health and Human Services, 2009. Available from: http://www. fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm204763.htm.Search in Google Scholar
Boshkov LK. Transfusion-related acute lung injury and the ICU. Crit Care Clin 2005;21:479–95.10.1016/j.ccc.2005.05.00515992669Search in Google Scholar
Boshkov LK. Transfusion-associated acute lung injury (TRALI): an evolving understanding of the role of anti-leukocyte antibodies. Vox Sang 2002;83(Suppl 1):299–303.10.1111/j.1423-0410.2002.tb05322.x12617157Search in Google Scholar
Barnard RD. Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. N Y State J Med 1951;51:2399–402.Search in Google Scholar
Brittingham TE. Immunologic studies on leukocytes. Vox Sang 1957;2:242–8.10.1111/j.1423-0410.1957.tb03699.x13496693Search in Google Scholar
Popovsky MA, Abel MD, Moore SB. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 1983;128:185–9.10.1164/arrd.1983.128.1.1856603182Search in Google Scholar
Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985;25:573–7.10.1046/j.1537-2995.1985.25686071434.x4071603Search in Google Scholar
Toy P, Popovsky MA, Abraham E, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005;33:721–6.10.1097/01.CCM.0000159849.94750.51Search in Google Scholar
Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004;44:1774–89.10.1111/j.0041-1132.2004.04347.x15584994Search in Google Scholar
Phua J, Stewart TE, Ferguson ND. Acute respiratory distress syndrome 40 years later: time to revisit its definition. Crit Care Med 2008;36:2912–21.10.1097/CCM.0b013e31817d20bd18766113Search in Google Scholar
Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334–49.10.1056/NEJM20000504342180610793167Search in Google Scholar
Palfi M, Berg S, Ernerudh J, Berlin G. A randomized controlled trial of transfusion-related acute lung injury: is plasma from multiparous blood donors dangerous? Transfusion 2001;41:317–22.10.1046/j.1537-2995.2001.41030317.x11274583Search in Google Scholar
Palfi M, Holthuis N. Does mild TRALI exist? Analysis of one year transfusion complications from south Sweden (abstract #M10.04). Vox Sang 2004;87 (Suppl 3):S4.Search in Google Scholar
Toy P, Hollis-Perry KM, Jun J, Nakagawa M. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion 2004;44:1683–8.10.1111/j.0041-1132.2004.04193.x15584980Search in Google Scholar
Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002;287:1968–71.10.1001/jama.287.15.196811960539Search in Google Scholar
Dry SM, Bechard KM, Milford EL, Churchill WH, Benjamin RJ. The pathology of transfusion-related acute lung injury. Am J Clin Pathol 1999;112:216–21.10.1093/ajcp/112.2.21610439802Search in Google Scholar
Wyman TH, Bjornsen AJ, Elzi DJ, et al. A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release. Am J Physiol Cell Physiol 2002;283:C1592– 603.10.1152/ajpcell.00540.200112388071Search in Google Scholar
Condliffe AM, Kitchen E, Chilvers ER. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin Sci (Lond) 1998;94:461–71.10.1042/cs09404619682667Search in Google Scholar
Silliman CC, Kelher M. The role of endothelial activation in the pathogenesis of transfusion-related acute lung injury. Transfusion 2005;45(Suppl):109S– 16S.10.1111/j.1537-2995.2005.00531.x16086797Search in Google Scholar
Fung YL, Silliman CC. The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. Transfus Med Rev 2009;23:266–83.10.1016/j.tmrv.2009.06.001293722119765516Search in Google Scholar
Silliman CC, Curtis BR, Kopko PM, et al. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause neutrophil-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 2007;109:1752–5.10.1182/blood-2006-05-025106179405517038531Search in Google Scholar
Kelher MR, Masuno T, Moore EE, et al. Plasma from stored packed red blood cells and MHC class 1 antibodies causes acute lung injury in a 2-event in vivo rat model. Blood 2009;113:2079–87.10.1182/blood-2008-09-177857265101819131548Search in Google Scholar
Seeger W, Schneider U, Kreusler B, et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 1990;76:1438–44.10.1182/blood.V76.7.1438.1438Search in Google Scholar
Sachs UJH, Hattar K, Weissmann N, et al. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood 2006;107:1217–19.10.1182/blood-2005-04-174416210340Search in Google Scholar
Lögdberg LE, Vikulina T, Zimring JC, Hillyer CD. Animal models of transfusion-related acute lung injury. Transfus Med Rev 2009;23:13–24.10.1016/j.tmrv.2008.09.00219056031Search in Google Scholar
Win N, Ranasinghe E, Lucas G. Transfusion-related acute lung injury: a 5-year look-back study. Transfus Med 2002;12:387–9.10.1046/j.1365-3148.2002.00401_1.x12473157Search in Google Scholar
Nicolle AL, Chapman CE, Carter V, Wallis JP. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation. Transfus Med 2004;14:225–30.10.1111/j.0958-7578.2004.00504.x15180814Search in Google Scholar
Davoren A, Curtis BR, Shulman IA, et al. TRALI due to granulocyte-agglutinating human neutrophil antigen3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion 2003;43:641–5.10.1046/j.1537-2995.2003.00374.x12702187Search in Google Scholar
Muniz M, Sheldon S, Schuller RM, et al. Patient-specific transfusion-related acute lung injury. Vox Sang 2008;94:70–3.Search in Google Scholar
Fadeyi EA, De Los Angeles Muniz M, Wayne AS, Klein HG, Leitman SF, Stroncek DF. The transfusion of neutrophil-specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions. Transfusion 2007;47:545–50.10.1111/j.1537-2995.2006.01148.x17319838Search in Google Scholar
Kopko PM, Paglieroni TG, Popovsky MA, Muto KN, MacKenzie MR, Holland PV. TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion 2003;43:177–84.10.1046/j.1537-2995.2003.00307.x12559013Search in Google Scholar
Gosselin EJ, Wardwell K, Rigby WF, Guyre PM. Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3. J Immunol 1993;151:1482–90.Search in Google Scholar
Kao GS, Wood IG, Dorfman DM, Milford EL, Benjamin RJ. Investigations into the role of anti-HLA class II antibodies in TRALI. Transfusion 2003;43:185–91.10.1046/j.1537-2995.2003.00285.x12559014Search in Google Scholar
Bux J, Sachs UJH. Pathophysiology of TRALI. In: Kleinman SH, Popovsky MA, eds. TRALI: mechanisms, management and prevention. Bethesda, MD: AABB Press, 2008:43–69.Search in Google Scholar
Nishimura M, Hashimoto S, Takanashi M, Okazaki H, Satake M, Nakajima K. Role of anti-human leucocyte antigen class II alloantibody and monocytes in development of transfusion-related acute lung injury. Transfus Med 2007;17:129–34.10.1111/j.1365-3148.2006.00721.x17430469Search in Google Scholar
Looney MR, Su X, Van Ziffle JA, Lowell CA, Matthay MA. Neutrophils and their Fcγ receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest 2006;116:1615–23.10.1172/JCI27238146294516710475Search in Google Scholar
Dykes A, Smallwood D, Kotsimbos T, Street A. Transfusion-related acute lung injury (TRALI) in a patient with a single lung transplant. Br J Haematol 2000;109:674–6.10.1046/j.1365-2141.2000.01999.x10886228Search in Google Scholar
Silliman CC, Paterson AJ, Dickey WO, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 1997;37:719–26.10.1046/j.1537-2995.1997.37797369448.x9225936Search in Google Scholar
Vercellotti GM, Yin HQ, Gustafson KS, Nelson RD, Jacob HS. Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Blood 1988;71:1100–7.10.1182/blood.V71.4.1100.1100Search in Google Scholar
Berkow RL, Wang D, Larrick JW, Dodson RW, Howard TH. Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. J Immunol 1987;139:3783–91.Search in Google Scholar
Daniels RH, Finnen MJ, Hill ME, Lackie JM. Recombinant human monocyte IL-8 primes NADPH-oxidase and phospholipase A2 activation in human neutrophils. Immunology 1992;75:157–63.Search in Google Scholar
Guthrie LA, McPhail LC, Henson PM, Johnston RB Jr. Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med 1984;160:1656–71.10.1084/jem.160.6.165621875296096475Search in Google Scholar
Silliman CC, Bjornsen AJ, Wyman TH, et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 2003;43:633–40.10.1046/j.1537-2995.2003.00385.x12702186Search in Google Scholar
Silliman CC, Voelkel NF, Allard JD, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 1998;101:1458–67.10.1172/JCI18415087249525989Search in Google Scholar
Silliman CC, Thurman GW, Ambruso DR. Stored blood components contain agents that prime the neutrophil NADPH oxidase through the platelet-activating-factor receptor. Vox Sang 1992;63:133–6.Search in Google Scholar
Silliman CC, Johnson CA, Clay KL, Thurman GW, Ambruso DR. Compounds biologically similar to platelet activating factor are present in stored blood components. Lipids 1993;28:415–18.10.1007/BF025359398316049Search in Google Scholar
Silliman CC, Clay KL, Thurman GW, Johnson CA, Ambruso DR. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 1994; 124:684–94.Search in Google Scholar
Khan SY, Kelher MR, Heal JM, et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006;108:2455–62.10.1182/blood-2006-04-017251189556416772606Search in Google Scholar
Silliman CC, Dickey WO, Paterson AJ, et al. Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion 1996;36:133–9.10.1046/j.1537-2995.1996.36296181925.x8614963Search in Google Scholar
Eder AF, Herron R, Strupp A, et al. Transfusion-related acute lung injury surveillance (2003–2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 2007;47:599–607.10.1111/j.1537-2995.2007.01102.x17381617Search in Google Scholar
Looney MR, Nguyen JX, Hu Y, Van Ziffle JA, Lowell CA, Matthay MA. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest 2009;119:3450–61.10.1172/JCI38432276918119809160Search in Google Scholar
Engelfriet CP, Reesink HW, Brand A, et al. Transfusion-related acute lung injury (TRALI). Vox Sang 2001;81:269–83.10.1046/j.0042-9007.2001.00115_1.x11904006Search in Google Scholar
Swanson K, Dwyre DM, Krochmal J, Raife TJ. Transfusion-related acute lung injury (TRALI): current clinical and pathophysiologic considerations. Lung 2006;184:177–85.10.1007/s00408-005-2578-816902843Search in Google Scholar
Bux J, Sachs UJH. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007;136:788–99.10.1111/j.1365-2141.2007.06492.x17341264Search in Google Scholar
Chapman CE, Stainsby D, Jones H, et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009;49:440–52.10.1111/j.1537-2995.2008.01948.x18980623Search in Google Scholar
Densmore TL, Goodnough LT, Ali S, Dynis M, Chaplin H. Prevalence of HLA sensitization in female apheresis donors. Transfusion 1999;39:103–6.10.1046/j.1537-2995.1999.39199116901.x9920173Search in Google Scholar
Triulzi DJ, Kleinman S, Kakaiya RM, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009;49:1825–35.10.1111/j.1537-2995.2009.02206.x284100119453983Search in Google Scholar
Hume HA. TRALI: moving toward prevention. Transfusion 2009;49:402–5.10.1111/j.1537-2995.2008.02090.x19243538Search in Google Scholar
Strong DM, Lipton KS. Transfusion-related acute lung injury. American Association of Blood Banks Bulletin#06-07, Nov 3, 2006.Search in Google Scholar
Eder AF, Herron RM Jr, Strupp A, et al. Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006–2008). Transfusion 2010 Apr 30 [Epub ahead of print].10.1111/j.1537-2995.2010.02652.x20456698Search in Google Scholar
Chapman CE, Williamson LM. UK hemovigilance and the preferential use of male plasma. In: Kleinman SH, Popovsky MA, eds. TRALI: mechanisms, management and prevention. Bethesda, MD: AABB Press, 2008:143–60.Search in Google Scholar
Sinnott P, Bodger S, Gupta A, et al. Presence of HLA antibodies in single-donor-derived fresh frozen plasma compared with pooled, solvent detergent-treated plasma (Octaplas). Eur J Immunogenet. 2004; 31:271–4.10.1111/j.1365-2370.2004.00481.x15548265Search in Google Scholar
Sachs UJ, Kauschat D, Bein G. White blood cell-reactive antibodies are undetectable in solvent/ detergent plasma. Transfusion. 2005;45:1628–31.10.1111/j.1537-2995.2005.00587.x16181214Search in Google Scholar
Triulzi DJ. Transfusion-related acute lung injury: current concepts for the clinician. Anesth Analg 2009; 108:770–6.10.1213/ane.0b013e31819029b219224781Search in Google Scholar
Mair DC, Hirschler N, Eastlund T. Blood donor and component management strategies to prevent transfusion-related acute lung injury (TRALI). Crit Care Med 2006;34(Suppl):S137–43.10.1097/01.CCM.0000214291.93884.BB16617258Search in Google Scholar
Greinacher A, Wesche J, Hammer E, et al. Characterization of the human neutrophil alloantigen3a. Nat Med 2010;16:45–8.10.1038/nm.207020037594Search in Google Scholar
Curtis BR, Cox NJ, Sullivan MJ, et al. The neutrophil alloantigen HNA-3a (5b) is located on choline transporter-like protein 2 and appears to be encoded by an R>Q154 amino acid substitution. Blood 2010 115:2073–6.10.1182/blood-2009-11-248336283733220040764Search in Google Scholar
Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 2005;105:2266–73.10.1182/blood-2004-07-292915572582Search in Google Scholar
Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J, Blajchman MA; TRALI Consensus Panel. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 2005;19: 2–31.10.1016/j.tmrv.2004.10.00115830325Search in Google Scholar
